Platelet function (measured by Platelet Function Analyser - 100) and obstructive sleep apnoea

Journal of Sleep Research

Volumn 14, Issue 3, 2005, Pages 325-327

  West, Sophie ^a   Segal, Helen ^a   Harrison, Paul ^a   Stradling, John ^a  

^a CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT;

ANALYZER; BLOOD FLOW VELOCITY; CARDIOVASCULAR RISK; DISEASE SEVERITY; DRUG EFFECT; DRUG MECHANISM; HEMOSTASIS; HUMAN; LETTER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SLEEP APNEA SYNDROME; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION;

ADULT; AGED; AGED, 80 AND OVER; BLOOD PLATELETS; FEMALE; FIBRINOGEN; HUMANS; MALE; MIDDLE AGED; P-SELECTIN; PLATELET FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; SLEEP APNEA, OBSTRUCTIVE;

EID: 24744455629     PISSN: 09621105     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2869.2005.00469.x     Document Type: Letter

References (18)

1. Boersma, E., Harrington, R. A., Moliterno, D. J., White, H., Theroux, P., Van de Werf, F., de Torbal, A., Armstrong, P. W., Wallentin, L. C., Wilcox, R. G., Simes, J., Califf, R. M., Topol, E. J. and Simoons, M. L. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials. Lancet, 2002, 359: 189-198.
2. Davies, R. J. Cardiovascular aspects of obstructive sleep apnoea and their relevance to the assessment of the efficacy of nasal continuous positive airway pressure therapy. Thorax, 1998, 53: 416-418.
3. Eisensehr, I., Ehrenberg, B. L., Noachtar, S., Korbett, K., Byrne, A., McAuley, A. and Palabrica, T. Platelet activation, epinephrine, and blood pressure in obstructive sleep apnea syndrome. Neurology, 1998, 51: 188-195.
4. Francis, J. L. (ed by A. D. Michelson), Platelet Function Analyzer (PFA-100). Platelets 2002, 325-335. Academic Press, San Diego.
5. Frossard, M., Fuchs, I., Leitner, J. M., Hsieh, K., Vlcek, M., Losert, H. et al. Platelet function predicts myocardial damage in patients with acute myocardial infarction. Circulation, 2004, 110: 1392-1397.
6. Harrison, P., Robinson, M., Liesner, R., Khair, K., Cohen, H., Mackie, I. and Machin, S. The PFA-100: a potential rapid screening tool for the assessment of platelet dysfunction. Clin. Lab. Haem., 2002, 24: 225-232.
7. Hui, D. S., Ko, F. W., Fok, J. P., Chan, M. C., Li, T. S., Tomlinson, B. et al. The effects of nasal continuous positive airway pressure on platelet activation in obstructive sleep apnea syndrome. Chest, 2004, 125: 1768-1775.
8. Jilma, B. Platelet function analyzer (PFA-100): a tool to quantify congenital or acquired platelet dysfunction. J. Lab. Clin. Med., 2001, 138: 152-163.
9. von Känel, R. and Dimsdale, J. E. Hemostatic alterations in patients with obstructive sleep apnea and the implications for cardiovascular disease. Chest, 2003, 124: 1956-1967.
10. Kundu, S. K., Heilmann, E. J., Sio, R., Garcia, C., Davidson, R. M. and Ostgaard, R. A. Description of an in vitro platelet function analyzer- PFA-100. Semin. Thromb. Hemost., 1995, 21 (Suppl. 2): 106-112.
11. Mammen, E. F., Comp, P. C., Gosselin, R., Greenberg, C., Hoots, W. K., Kessler, C. M., Larkin, E. C., Liles, D. and Nugent, D. J. PFA-100 system: a new method for assessment of platelet dysfunction. Semin. Thromb. Hemost., 1998, 24: 195-202.
12. Marin, J. M., Carrizo, S. J., Vicente, E. and Agusti, A. G. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet, 2005, 365: 1046-1053.
13. Ott, I., Neumann, F. J., Gawaz, M., Schmitt, M. and Schomig, A. Increased neutrophil-platelet adhesion in patients with unstable angina. Circulation, 1996, 94: 1239-1246.
14. Peppard, P. E., Young, T., Palta, M. and Skatrud, J. Prospective study of the association between sleep-disordered breathing and hypertension. N. Engl. J. Med., 2000, 342: 1378-1384.
15. Robinson, G. V., Pepperell, J. C., Segal, H. C., Davies, R. J. and Stradling, J. R. Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials. Thorax, 2004, 59: 777-782.
16. Wessendorf, T. E., Thilmann, A. F., Wang, Y. M., Schreiber, A., Konietzko, N. and Teschler, H. Fibrinogen levels and obstructive sleep apnea in ischemic stroke. Am. J. Respir. Crit. Care Med., 2000, 162: 2039-2042.
17. Wodlinger, A. M. and Pieper, J. A. The role of clopidogrel in the management of acute coronary syndromes. Clin. Ther., 2003, 25: 2155-2181.
18. Yusuf, S., Mehta, S. R., Zhao, F., Gersh, B. J., Commerford, P. J., Blumenthal, M., Budaj, A., Wittlinger, T. and Fox, K. A. Early and late effects of clopidogrel in patients with acute coronary syndromes. Circulation, 2003, 107: 966-972.